Literature DB >> 10701146

The key role of macrophages in the immunopathogenesis of inflammatory bowel disease.

Y R Mahida1.   

Abstract

Macrophages are important in the host's immunological and inflammatory responses. There is a large population of these cells in the normal intestinal mucosa where they represent the major antigen presenting cell population capable of determining the type of T cell responses that develop to luminal antigens. Studies suggest that the normal intestinal macrophages cannot be easily induced to mediate acute inflammatory responses. In active inflammatory bowel disease there is an increase in the mucosal macrophage population, derived from circulating monocytes. These recruited macrophages are phenotypically different from the resident population of cells and play a major role in mediating the chronic mucosal inflammation seen in patients with ulcerative colitis and Crohn's disease. They secrete many cytokines that are important in the proinflammatory responses, such as interleukin (IL)-1, IL-6, IL-8, IL-12, IL-18, and tumor necrosis factor-alpha. They also release reactive metabolites of oxygen and nitrogen and proteases that degrade the extracellular matrix. Macrophages also appear to be important during resolution of inflammation and repair of the intestinal mucosa that occurs during disease remission.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701146     DOI: 10.1097/00054725-200002000-00004

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  87 in total

1.  Regulation of alpha1-proteinase inhibitor release by proinflammatory cytokines in human intestinal epithelial cells.

Authors:  D Faust; K Raschke; S Hormann; V Milovic; J Stein
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease.

Authors:  S Koch; T Kucharzik; J Heidemann; A Nusrat; A Luegering
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

3.  Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease.

Authors:  S Dionne; S Laberge; C Deslandres; E G Seidman
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

Review 4.  Evaluation of new therapies for inflammatory bowel disease.

Authors:  E Carty; D S Rampton
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

Review 5.  The role of LIGHT in T cell-mediated immunity.

Authors:  Jing Wang; Yang-Xin Fu
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

6.  Cytapheresis in patients with severe ulcerative colitis after failure of intravenous corticosteroid: a long-term retrospective cohort study.

Authors:  Ken Fukunaga; Kazuko Nagase; Takeshi Kusaka; Nobuyuki Hida; Yoshio Ohda; Koji Yoshida; Katsuyuki Tozawa; Koji Kamikozuru; M Iimuro; Shiro Nakamura; Hiroto Miwa; Takayuki Matsumoto
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

7.  Functional role of the 503F variant of the organic cation transporter OCTN1 in Crohn's disease.

Authors:  D Taubert; G Grimberg; N Jung; A Rubbert; E Schömig
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

8.  Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.

Authors:  Immanuel Lerner; Esther Hermano; Eyal Zcharia; Dina Rodkin; Raanan Bulvik; Victoria Doviner; Ariel M Rubinstein; Rivka Ishai-Michaeli; Ruth Atzmon; Yoav Sherman; Amichay Meirovitz; Tamar Peretz; Israel Vlodavsky; Michael Elkin
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

9.  Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice.

Authors:  Norihiko Watanabe; Koichi Ikuta; Kazuichi Okazaki; Hiroshi Nakase; Yasuhiko Tabata; Minoru Matsuura; Hiroyuki Tamaki; Chiharu Kawanami; Tasuku Honjo; Tsutomu Chiba
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

10.  IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation.

Authors:  B Siegmund; H A Lehr; G Fantuzzi; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.